Pages that link to "Q28194912"
Jump to navigation
Jump to search
The following pages link to Polypill holds promise for people with chronic disease (Q28194912):
Displaying 13 items.
- The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries (Q28212291) (← links)
- Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania (Q28219296) (← links)
- Current and future perspectives on the management of polypharmacy (Q33454888) (← links)
- Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis) (Q34240747) (← links)
- Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population (Q34909942) (← links)
- Management of NCD in low- and middle-income countries (Q34987612) (← links)
- Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction (Q36469832) (← links)
- How can we achieve global equity in provision of renal replacement therapy? (Q37108693) (← links)
- Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population (Q37154445) (← links)
- Could patents interfere with the development of a cardiovascular polypill? (Q37189186) (← links)
- Issues to consider in the pharmaceutical development of a cardiovascular polypill (Q37357028) (← links)
- Fixed drug combination in hypertension and hyperlipidaemia in the developing world. (Q37682478) (← links)
- Polypill and Global Cardiovascular Health Strategies (Q37909659) (← links)